High Quality Imatinib Mesylate CAS NO.220127-57-1

 Qingdao Sigma Chemical Ltd is is a global chemical industry manufacturers and suppliers of pharmaceuticals and intermediates, peptide,Nootropis etc API, food and feed additives, herbal extracts, agrochemicals and fine chemicals etc.

 

Our Laboratory is located in shandong province. There are 15 experts in our research team. Talented personnel and well-equipped laboratory makes rigorous and professional quality control possible. Lyphar Biotech is equipped with various detection devices, such as HPLC, GC, Spectrophotometer, AAS, Polarimeter, Auto titrators, BOD Incubators, COD Incubators, Melting point apparatus and so on.

 

The aim of QDSIGMA is a quality policy that "Elements in the system all have been satisfied, Personnel has been trained; Every batch of material is checked, Each procedure guarantees the quality; Every bag of our products is top grade, Service is thoughtful all the time, quality and reputation to increase market share and promote enterprise development. The quality, colors and forms of our products have reached a high level in related chemical industry, which relies on characteristic and advanced processing technology and it has gained a high and reliable reputation from customers at both quality and services.

 

QDSIGMA has become the "Top 500 Chinese manufacturing companies","Top 20 of global chemical sales".QDSIGMA has 21 subsidiaries and holding companies.

Product Name: Imatinib mesylate

Appearance: white  powder

Specification :99%Min

CAS : 220127-57-1 

 

Certification of 220127-57-1

Imatinib mesylate	CAS :220127-57-1	Brand:Hyper
	MW:   C29H31N7O.CH4O3S	MSDS: Avaiable
	MF :589.71	Sample: Avaiable
	Category: Oncology drug	Min order: 10grams
	Quality standard: USP,EP	Place of Origin:China
Introduction	Imatinib, an antineoplastic drug is used to treat chronic myeloid leukemia and gastrointestinal stromal tumours
Character	White to Almost white powder.

 

More information of 220127-57-1

Storage:Store in cool & dry place.Keep away from strong light and heat. 

 

Imatinib mesylate (also called Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl, the causal agent in chronic myelogenous leukemia.

 

As an inhibitor of PDGFR, imatinib mesylate appears to have utility in the treatment of a variety of dermatological diseases. Imatinib has been reported to be an effective treatment for FIP1L1-PDGFRalpha+ mast cell disease, hypereosinophilic syndrome, and dermatofibrosarcoma protuberans.

d sulfuric acid
.